Jeffrey Clarke
ORCID: 0000-0001-5647-0245Also affiliated with Duke Cancer Institute
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 9 papers. Top paper: “Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial”.
Brian A. Van Tine, Swethajit Biswas, Cheryl McAlpine, Melissa L. Johnson, Anthony J. Olszanski +39 more
Victoria M. Raymond, Richard B. Lanman, Jacqulyne Robichaux, Junqin He, Monique B. Nilsson +17 more
Tyler A. Allen, Muthana Al Abo, Xiaodi Qin, Dadong Zhang, Brendon M. Patierno +13 more
Amanda E.D. Van Swearingen, Meghan Price, Ketan R. Bulsara, Roeland Verhaak, César Baëta +9 more
R.F. Shenker, Peter G. Hendrickson, Zihan Wan, Donna Niedzwiecki, Sebastian Winter +12 more
R.F. Shenker, Peter G. Hendrickson, Zihan Wan, Donna Niedzwiecki, David Carpenter +14 more
Victor Moreno, Kathleen Moore, Adam Asch, Brian A. Van Tine, John Charlson +31 more
Hongliang Liu, Sheng Luo, Jeffrey Clarke, Carolyn Glass, Li Su +4 more
Yu Zhao, Hongliang Liu, Sheng Luo, Jeffrey Clarke, Carolyn Glass +6 more